SEC Tracker
Get the app

PMV Pharmaceuticals PMVP

OrbiMed Genesis Master Fund (Shareholder) plans to sell 87,786 PMVP shares, about $197,519

Form
144
Filed
Importance
Routine
  1. Approximate sale date: Nov 22, 2023
  2. Broker: Themis Trading LLC
  3. Shares acquired by: Initial Public Offering

All of OrbiMed Genesis Master Fund's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 87,786 shares at $2.23 on Nov 22, 2023 · Form 4

Written from the Form 144 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when PMV Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Avalo Therapeutics AVTX public float $54M, Jun 30, 2025
  2. Cue Biopharma CUE public float $52M, Jun 30, 2025
  3. Fitlife Brands FTLF public float $51M, Jun 30, 2025
  4. Immucell ICCC public float $51M, Jun 30, 2025
  5. iBio IBIO public float $58M, Dec 31, 2025